9214 Stock Overview
Recovery International Co.,Ltd. offers home-visit nursing and rehabilitation in-home nursing care services in Japan.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Recovery International Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥1,757.00 |
52 Week High | JP¥3,335.00 |
52 Week Low | JP¥1,700.00 |
Beta | 0.58 |
1 Month Change | -7.43% |
3 Month Change | -19.40% |
1 Year Change | -9.53% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -28.92% |
Recent News & Updates
Recent updates
Shareholder Returns
9214 | JP Healthcare | JP Market | |
---|---|---|---|
7D | -0.7% | 3.0% | 2.2% |
1Y | -9.5% | 3.2% | 27.7% |
Return vs Industry: 9214 underperformed the JP Healthcare industry which returned 3.2% over the past year.
Return vs Market: 9214 underperformed the JP Market which returned 27.7% over the past year.
Price Volatility
9214 volatility | |
---|---|
9214 Average Weekly Movement | 3.6% |
Healthcare Industry Average Movement | 3.7% |
Market Average Movement | 4.1% |
10% most volatile stocks in JP Market | 8.1% |
10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 9214 has not had significant price volatility in the past 3 months.
Volatility Over Time: 9214's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 224 | Junya Shibata | www.recovery-group.co.jp |
Recovery International Co.,Ltd. offers home-visit nursing and rehabilitation in-home nursing care services in Japan. It provides home-visit nursing care for people with illness or disability patients; physical, occupational therapists, and speech language pathologists services to maintain and restore mental and physical functions; and home-visit massage services for physically handicapped patients.
Recovery International Co.,Ltd. Fundamentals Summary
9214 fundamental statistics | |
---|---|
Market cap | JP¥2.48b |
Earnings (TTM) | JP¥110.00m |
Revenue (TTM) | JP¥1.61b |
22.6x
P/E Ratio1.5x
P/S RatioIs 9214 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9214 income statement (TTM) | |
---|---|
Revenue | JP¥1.61b |
Cost of Revenue | JP¥958.00m |
Gross Profit | JP¥647.00m |
Other Expenses | JP¥537.00m |
Earnings | JP¥110.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
Earnings per share (EPS) | 77.79 |
Gross Margin | 40.31% |
Net Profit Margin | 6.85% |
Debt/Equity Ratio | 2.6% |
How did 9214 perform over the long term?
See historical performance and comparison